Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Early-onset (age < 65) Alzheimer’s disease is associated with greater non-amnestic cognitive symptoms and neuropathological burden than late-onset disease. It is not fully understood whether these groups also differ in the associations between molecular pathology, neurodegeneration and cognitive performance. We studied amyloid-positive patients with early-onset (n = 60, mean age 58 ± 4, MMSE 21 ± 6, 58% female) and late-onset (n = 53, mean age 74 ± 6, MMSE 23 ± 5, 45% female) Alzheimer’s disease who underwent neurological evaluation, neuropsychological testing, 11C-Pittsburgh compound B PET (amyloid-PET) and 18F-flortaucipir PET (tau-PET). 18F-fluorodeoxyglucose PET (brain glucose metabolism PET) was also available in 74% (n = 84) of participants. Composite scores for episodic memory, semantic memory, language, executive function and visuospatial domains were calculated based on cognitively unimpaired controls. Voxel-wise regressions evaluated correlations between PET biomarkers and cognitive scores and early-onset versus late-onset differences were tested with a PET × Age group interaction. Mediation analyses estimated direct and indirect (18F-fluorodeoxyglucose mediated) local associations between 18F-flortaucipir binding and cognitive scores in domain-specific regions of interest. We found that early-onset patients had higher 18F-flortaucipir binding in parietal, lateral temporal and lateral frontal cortex; more severe 18F-fluorodeoxyglucose hypometabolism in the precuneus and angular gyrus; and greater 11C-Pittsburgh compound B binding in occipital regions compared to late-onset patients. In our primary analyses, PET–cognition correlations did not meaningfully differ between age groups.18F-flortaucipir and 18F-fluorodeoxyglucose, but not 11C-Pittsburgh compound B, were significantly associated with cognition in expected domain-specific patterns in both age groups (e.g. left perisylvian/language, frontal/executive, occipital/visuospatial). 18F-fluorodeoxyglucose mediated the relationship between 18F-flortaucipir and cognition in both age groups across all domains except episodic memory in late-onset patients. Additional direct effects of 18F-flortaucipir were observed for executive function in all age groups, language in early-onset Alzheimer’s disease and in the total sample and visuospatial function in the total sample. In conclusion, tau and neurodegeneration, but not amyloid, were similarly associated with cognition in both early and late-onset Alzheimer’s disease. Tau had an association with cognition independent of neurodegeneration in language, executive and visuospatial functions in the total sample. Our findings support tau PET as a biomarker that captures both the clinical severity and molecular pathology specific to Alzheimer’s disease across the broad spectrum of ages and clinical phenotypes in Alzheimer’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BrainNet Viewer: A Network Visualization Tool for Human Brain Connectomics
Xia, M., Wang, J., & He, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068910 · Cited by 4,106
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
Evidence for a Frontoparietal Control System Revealed by Intrinsic Functional Connectivity
Vincent, J. L., Kahn, I., Snyder, A. Z., Raichle, M. E., & Buckner, R. L. (2008) · Journal of Neurophysiology · doi:10.1152/jn.90355.2008 · Cited by 1,869
Donanemab in Early Alzheimer’s Disease
Mintun, M. A., Lo, A. C., Duggan Evans, C., Wessels, A. M., Ardayfio, P. A., Andersen, S. W., Shcherbinin, S., Sparks, J., Sims, J. R., Brys, M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2100708 · Cited by 1,728
PET Imaging of Tau Deposition in the Aging Human Brain
Schöll, M., Lockhart, S. N., Schonhaut, D. R., O’Neil, J. P., Janabi, M., Ossenkoppele, R., Baker, S. L., Vogel, J. W., Faria, J., Schwimmer, H. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.028 · Cited by 1,214
Self-citationTau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
Ossenkoppele, R., Schonhaut, D. R., Schöll, M., Lockhart, S. N., Ayakta, N., Baker, S. L., O’Neil, J. P., Janabi, M., Lazaris, A., Cantwell, A., et al. (2016) · Brain · doi:10.1093/brain/aww027 · Cited by 1,185
Self-citationTangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease
Giannakopoulos, P., Herrmann, F. R., Bussière, T., Bouras, C., Kövari, E., Perl, D. P., Morrison, J. H., Gold, G., & Hof, P. R. (2003) · Neurology · doi:10.1212/01.wnl.0000063311.58879.01 · Cited by 1,118
Murray, M. E., Graff-Radford, N. R., Ross, O. A., Petersen, R. C., Duara, R., & Dickson, D. W. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70156-9 · Cited by 972
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
Jack, C. R., Wiste, H. J., Weigand, S. D., Therneau, T. M., Lowe, V. J., Knopman, D. S., Gunter, J. L., Senjem, M. L., Jones, D. T., Kantarci, K., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.08.005 · Cited by 931
Age, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900
Campion, D., Dumanchin, C., Hannequin, D., Dubois, B., Belliard, S., Puel, M., Thomas-Anterion, C., Michon, A., Martin, C., Charbonnier, F., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302553 · Cited by 785
Four distinct trajectories of tau deposition identified in Alzheimer’s disease
Initiative, T. A. D. N., Vogel, J. W., Young, A. L., Oxtoby, N. P., Smith, R., Ossenkoppele, R., Strandberg, O. T., La Joie, R., Aksman, L. M., Grothe, M. J., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01309-6 · Cited by 741
Self-citationTau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
Brier, M. R., Gordon, B., Friedrichsen, K., McCarthy, J., Stern, A., Christensen, J., Owen, C., Aldea, P., Su, Y., Hassenstab, J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf2362 · Cited by 734
Robinson, J. L., Lee, E. B., Xie, S. X., Rennert, L., Suh, E., Bredenberg, C., Caswell, C., Van Deerlin, V. M., Yan, N., Yousef, A., et al. (2018) · Brain · doi:10.1093/brain/awy146 · Cited by 729
Self-citationConsensus classification of posterior cortical atrophy
Crutch, S. J., Schott, J. M., Rabinovici, G. D., Murray, M., Snowden, J. S., van der Flier, W. M., Dickerson, B. C., Vandenberghe, R., Ahmed, S., Bak, T. H., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.014 · Cited by 665
Self-citationEarly clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807
Chien, D. T., Bahri, S., Szardenings, A. K., Walsh, J. C., Mu, F., Su, M.-Y., Shankle, W. R., Elizarov, A., & Kolb, H. C. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122059 · Cited by 651
Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis
Viola, K. L., & Klein, W. L. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1386-3 · Cited by 628
Molecular genetics of early-onset Alzheimer’s disease revisited
Cacace, R., Sleegers, K., & Van Broeckhoven, C. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.01.012 · Cited by 617
La Joie, R., Visani, A. V., Baker, S. L., Brown, J. A., Bourakova, V., Cha, J., Chaudhary, K., Edwards, L., Iaccarino, L., Janabi, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aau5732 · Cited by 612
Self-citation[ 18 F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
Xia, C., Arteaga, J., Chen, G., Gangadharmath, U., Gomez, L. F., Kasi, D., Lam, C., Liang, Q., Liu, C., Mocharla, V. P., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.11.008 · Cited by 605
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
Maass, A., Landau, S., Baker, S. L., Horng, A., Lockhart, S. N., La Joie, R., Rabinovici, G. D., & Jagust, W. J. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.05.058 · Cited by 462
Self-citationFleisher, A. S., Pontecorvo, M. J., Devous, M. D., Lu, M., Arora, A. K., Truocchio, S. P., Aldea, P., Flitter, M., Locascio, T., Devine, M., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.0528 · Cited by 448
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
Dujardin, S., Commins, C., Lathuiliere, A., Beerepoot, P., Fernandes, A. R., Kamath, T. V., De Los Santos, M. B., Klickstein, N., Corjuc, D. L., Corjuc, B. T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0938-9 · Cited by 438
Villeneuve, S., Rabinovici, G. D., Cohn-Sheehy, B. I., Madison, C., Ayakta, N., Ghosh, P. M., La Joie, R., Arthur-Bentil, S. K., Vogel, J. W., Marks, S. M., et al. (2015) · Brain · doi:10.1093/brain/awv112 · Cited by 408
Self-citationMontenigro, P. H., Baugh, C. M., Daneshvar, D. H., Mez, J., Budson, A. E., Au, R., Katz, D. I., Cantu, R. C., & Stern, R. A. (2014) · Alzheimer's Research & Therapy · doi:10.1186/s13195-014-0068-z · Cited by 375
Pontecorvo, M. J., Devous, M. D., Navitsky, M., Lu, M., Salloway, S., Schaerf, F. W., Jennings, D., Arora, A. K., McGeehan, A., Lim, N. C., et al. (2017) · Brain · doi:10.1093/brain/aww334 · Cited by 357
Epidemiology of early-onset dementia: a review of the literature
Vieira, R. T., Caixeta, L., Machado, S., Silva, A. C., Nardi, A. E., Arias-Carrión, O., & Carta, M. G. (2013) · Clinical Practice & Epidemiology in Mental Health · doi:10.2174/1745017901309010088 · Cited by 325
La Joie, R., Ayakta, N., Seeley, W. W., Borys, E., Boxer, A. L., DeCarli, C., Doré, V., Grinberg, L. T., Huang, E., Hwang, J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.09.001 · Cited by 317
Self-citationComorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease
Spina, S., La Joie, R., Petersen, C., Nolan, A. L., Cuevas, D., Cosme, C., Hepker, M., Hwang, J.-H., Miller, Z. A., Huang, E. J., et al. (2021) · Brain · doi:10.1093/brain/awab099 · Cited by 278
Self-citationJacobs, D., Sano, M., Marder, K., Bell, K., Bylsma, F., Lafleche, G., Albert, M., Brandt, J., & Stern, Y. (1994) · Neurology · doi:10.1212/wnl.44.7.1215 · Cited by 266
Brain fluorodeoxyglucose (FDG) PET in dementia
Kato, T., Inui, Y., Nakamura, A., & Ito, K. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.02.003 · Cited by 236
Pathological Tau Disrupts Ongoing Network Activity
Menkes-Caspi, N., Yamin, H. G., Kellner, V., Spires-Jones, T. L., Cohen, D., & Stern, E. A. (2015) · Neuron · doi:10.1016/j.neuron.2015.01.025 · Cited by 184
Early onset Alzheimer’s disease is associated with a distinct neuropsychological profile
Smits, L. L., Pijnenburg, Y. A. L., Koedam, E. L. G. E., van der Vlies, A. E., Reuling, I. E. W., Koene, T., Teunissen, C. E., Scheltens, P., & van der Flier, W. M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111934 · Cited by 182
The Accurate Diagnosis of Early-Onset Dementia
Mendez, M. F. (2006) · The International Journal of Psychiatry in Medicine · doi:10.2190/q6j4-r143-p630-kw41 · Cited by 181
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer’s disease
Schöll, M., Ossenkoppele, R., Strandberg, O., Palmqvist, S., study, T. S. B., Jögi, J., Ohlsson, T., Smith, R., & Hansson, O. (2017) · Brain · doi:10.1093/brain/awx171 · Cited by 180
Ossenkoppele, R., Lyoo, C. H., Jester-Broms, J., Sudre, C. H., Cho, H., Ryu, Y. H., Choi, J. Y., Smith, R., Strandberg, O., Palmqvist, S., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.5154 · Cited by 161
Berti (2014) · doi:10.1016/j.cpet.2013.10.006 · Cited by 152
Early-onset Alzheimer’s disease is associated with greater pathologic burden.
Marshall, G. A., Fairbanks, L. A., Tekin, S., Vinters, H. V., & Cummings, J. L. (2007) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706297086 · Cited by 143
Amyloid burden and metabolic function in early-onset Alzheimer’s disease: parietal lobe involvement.
Ossenkoppele, R., Zwan, M. D., Tolboom, N., van Assema, D. M. E., Adriaanse, S. F., Kloet, R. W., Boellaard, R., Windhorst, A. D., Barkhof, F., Lammertsma, A. A., et al. (2012) · Brain · doi:10.1093/brain/aws113 · Cited by 123
Early onset dementia: clinical and social aspects
Werner, P., Stein-Shvachman, I., & Korczyn, A. D. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209009223 · Cited by 122
Predicting future rates of tau accumulation on PET
Jack, C. R., Wiste, H. J., Weigand, S. D., Therneau, T. M., Lowe, V. J., Knopman, D. S., Botha, H., Graff-Radford, J., Jones, D. T., Ferman, T. J., et al. (2020) · Brain · doi:10.1093/brain/awaa248 · Cited by 117
Language and behavior domains enhance the value of the clinical dementia rating scale
Knopman, D. S., Weintraub, S., & Pankratz, V. S. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.12.006 · Cited by 105
Driscoll, I., Troncoso, J. C., Rudow, G., Sojkova, J., Pletnikova, O., Zhou, Y., Kraut, M. A., Ferrucci, L., Mathis, C. A., Klunk, W. E., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1025-1 · Cited by 104
Progressive Tau Accumulation in Alzheimer Disease: 2-Year Follow-up Study
Cho, H., Choi, J. Y., Lee, H. S., Lee, J. H., Ryu, Y. H., Lee, M. S., Jack, C. R., & Lyoo, C. H. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.221697 · Cited by 94
Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease
Strom, A., Iaccarino, L., Edwards, L., Lesman-Segev, O. H., Soleimani-Meigooni, D. N., Pham, J., Baker, S. L., Landau, S. M., Jagust, W. J., Miller, B. L., et al. (2022) · Brain · doi:10.1093/brain/awab294 · Cited by 91
Self-citationNeocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease
Phillips, J. S., Da Re, F., Dratch, L., Xie, S. X., Irwin, D. J., McMillan, C. T., Vaishnavi, S. N., Ferrarese, C., Lee, E. B., Shaw, L. M., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.11.008 · Cited by 74
Amyloid-β Oligomers Relate to Cognitive Decline in Alzheimer's Disease
Jongbloed, W., Bruggink, K. A., Kester, M. I., Visser, P.-J., Scheltens, P., Blankenstein, M. A., Verbeek, M. M., Teunissen, C. E., & Veerhuis, R. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142136 · Cited by 68
Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease
Phillips, J. S., Das, S. R., McMillan, C. T., Irwin, D. J., Roll, E. E., Da Re, F., Nasrallah, I. M., Wolk, D. A., & Grossman, M. (2018) · Human Brain Mapping · doi:10.1002/hbm.23874 · Cited by 68
Research works printed but not linked: 63
- Lambert, 2014, Estimating the burden of early onset dementia; Systematic review of disease prevalence, Eur J Neurol, 21, 563, 10.1111/ene.12325 · DOI · Paper page
- Zhu, 2015, Rate of early onset Alzheimer’s disease: A systematic review and meta-analysis, Ann Transl Med, 3, 38
- Jarmolowicz, 2015, The patterns of inheritance in early-onset dementia: Alzheimer’s disease and frontotemporal dementia, Am J Alzheimers Dis Other Demen, 30, 299, 10.1177/1533317514545825 · DOI · Paper page
- Ho, 2002, Age at onset is associated with disease severity in Lewy body variant and Alzheimer’s disease, Neuroreport, 13, 1825, 10.1097/00001756-200210070-00028 · DOI · Paper page
- Davidson, 2011, TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s syndrome: Association with age, hippocampal sclerosis and clinical phenotype, Acta Neuropathol, 122, 703, 10.1007/s00401-011-0879-y · DOI
- Lawlor, 1994, Clinical symptoms associated with age at onset in Alzheimer’s disease, The American Journal of Psychiatry, 151, 1646, 10.1176/ajp.151.11.1646 · DOI · Paper page
- Palasí, 2015, Differentiated clinical presentation of early and late-onset Alzheimer’s disease: Is 65 years of age providing a reliable threshold?, J Neurol, 262, 1238, 10.1007/s00415-015-7698-3 · DOI
- Joubert, 2016, Early-onset and late-onset Alzheimer’s disease are associated with distinct patterns of memory impairment, Cortex, 74, 217, 10.1016/j.cortex.2015.10.014 · DOI
- Mendez, 2017, Neurol Clin, 35, 263, 10.1016/j.ncl.2017.01.005 · DOI · Paper page
- Bentham, 2005, Services for younger people with dementia, Psychiatry, 4, 100, 10.1383/psyt.4.2.100.59105 · DOI
- Wattmo, 2017, Early- versus late-onset Alzheimer’s disease in clinical practice: Cognitive and global outcomes over 3 years, Alzheimers Res Ther, 9, 70, 10.1186/s13195-017-0294-2 · DOI · Paper page
- Chang, 2017, Mortality risk after diagnosis of early-onset Alzheimer’s disease versus late-onset Alzheimer’s disease: A propensity score matching analysis, J Alzheimers Dis, 56, 1341, 10.3233/JAD-161181 · DOI
- Klunk, 2004, Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B, Ann Neurol, 55, 306, 10.1002/ana.20009 · DOI · Paper page
- Cho, 2013, Amyloid deposition in early onset versus late onset Alzheimer’s disease, J Alzheimers Dis, 35, 813, 10.3233/JAD-121927 · DOI · Paper page
- Rabinovici, 2010, Increased metabolic vulnerability in early-onset Alzheimer’s disease is not related to amyloid burden, Brain, 133, 512, 10.1093/brain/awp326 · DOI · Paper page
- La Joie, 2021, Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau- and amyloid-PET, Neurology, 96, e650, 10.1212/WNL.0000000000011270 · DOI · Paper page
- Marquié, 2015, Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue, Ann Neurol, 78, 787, 10.1002/ana.24517 · DOI · Paper page
- Whitwell, 2018, Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer’s disease, Alzheimers Dement, 14, 1005, 10.1016/j.jalz.2018.02.020 · DOI · Paper page
- Iaccarino, 2021, Spatial relationships between molecular pathology and neurodegeneration in the Alzheimer’s disease continuum, Cereb Cortex, 31, 1, 10.1093/cercor/bhaa184 · DOI · Paper page
- Josephs, 2020, MRI And flortaucipir relationships in Alzheimer’s phenotypes are heterogeneous, Ann Clin Transl Neurol, 7, 707, 10.1002/acn3.51038 · DOI
- Visser, 2020, Tau pathology and relative cerebral blood flow are independently associated with cognition in Alzheimer’s disease, Eur J Nucl Med Mol Imaging, 47, 3165, 10.1007/s00259-020-04831-w · DOI
- Kim, 2005, Glucose metabolism in early onset versus late onset Alzheimer’s disease: An SPM analysis of 120 patients, Brain, 128, 1790, 10.1093/brain/awh539 · DOI · Paper page
- Aziz, 2017, Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer’s disease, Neurobiol Aging, 54, 22, 10.1016/j.neurobiolaging.2017.02.010 · DOI
- Lehmann, 2013, Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer’s disease, Brain, 136, 844, 10.1093/brain/aws327 · DOI · Paper page
- Koychev, 2017, PET Tau and amyloid-β burden in mild Alzheimer’s disease: Divergent relationship with age, cognition, and cerebrospinal fluid biomarkers, J Alzheimers Dis, 60, 283, 10.3233/JAD-170129 · DOI · Paper page
- Bejanin, 2017, Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease, Brain, 140, 3286, 10.1093/brain/awx243 · DOI · Paper page
- Digma, 2019, Tau and atrophy: Domain-specific relationships with cognition, Alzheimers Res Ther, 11, 65, 10.1186/s13195-019-0518-8 · DOI
- Sintini, 2019, Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer’s disease, Hum Brain Mapp, 40, 1618, 10.1002/hbm.24473 · DOI · Paper page
- Boon, 2020, The coarse-grained plaque: a divergent aβ plaque-type in early-onset Alzheimer’s disease, Acta Neuropathol, 140, 811, 10.1007/s00401-020-02198-8 · DOI · Paper page
- McKhann, 2011, The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease, Alzheimers Dement, 7, 263, 10.1016/j.jalz.2011.03.005 · DOI · Paper page
- Albert, 2011, The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease, Alzheimers Dement, 7, 270, 10.1016/j.jalz.2011.03.008 · DOI · Paper page
- Gorno-Tempini, 2011, Classification of primary progressive aphasia and its variants, Neurology, 76, 1006, 10.1212/WNL.0b013e31821103e6 · DOI · Paper page
- Kramer, 2003, Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease, Cogn Behav Neurol, 16, 211, 10.1097/00146965-200312000-00002 · DOI · Paper page
- Nys, 2005, Restrictions of the Mini-Mental State Examination in acute stroke, Arch Clin Neuropsychol, 20, 623, 10.1016/j.acn.2005.04.001 · DOI · Paper page
- Lesman-Segev, 2019, Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy, Neuroimage Clin, 24, 102025, 10.1016/j.nicl.2019.102025 · DOI
- Baker, 2017, Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data, Data Brief, 15, 648, 10.1016/j.dib.2017.10.024 · DOI · Paper page
- Müller-Gärtner, 1992, Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects, J Cereb Blood Flow Metab, 12, 571, 10.1038/jcbfm.1992.81 · DOI · Paper page
- MATLAB, 2015, Version 8.5.0.197613(R2015a)
- Wickham, 2009, Ggplot2: Elegant graphics for data analysis, 10.1007/978-0-387-98141-3 · DOI · Paper page
- Tingley, 2014, Mediation: R package for causal mediation analysis, J Stat Softw, 59, 1, 10.18637/jss.v059.i05 · DOI · Paper page
- Petersen, 2019, Alzheimer’s disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation, Acta Neuropathol, 138, 597, 10.1007/s00401-019-02036-6 · DOI · Paper page
- Furst, 2012, Cognition, glucose metabolism and amyloid burden in Alzheimer’s disease, Neurobiol Aging, 33, 215, 10.1016/j.neurobiolaging.2010.03.011 · DOI · Paper page
- Ossenkoppele, 2019, Associations between tau, aβ, and cortical thickness with cognition in Alzheimer disease, Neurology, 92, e601, 10.1212/WNL.0000000000006875 · DOI · Paper page
- Villemagne, 2013, Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: A prospective cohort study, Lancet Neurol, 12, 357, 10.1016/S1474-4422(13)70044-9 · DOI · Paper page
- Santos, 2012, Amyloid-β oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer’s disease, J Alzheimers Dis, 29, 171, 10.3233/JAD-2012-111361 · DOI · Paper page
- Meng, 2019, Association between increased levels of amyloid-β oligomers in plasma and episodic memory loss in Alzheimer’s disease, Alzheimers Res Ther, 11, 89, 10.1186/s13195-019-0535-7 · DOI
- Posner, 1988, Localization of cognitive operations in the human brain, Science, 240, 1627, 10.1126/science.3289116 · DOI · Paper page
- Chertkow, 2008, Cognitive neuroscience studies of semantic memory in Alzheimer’s disease, Prog Brain Res, 169, 393, 10.1016/S0079-6123(07)00025-8 · DOI
- Peelle, 2014, Frontotemporal neural systems supporting semantic processing in Alzheimer’s disease, Cogn Affect Behav Neurosci, 14, 37, 10.3758/s13415-013-0239-6 · DOI
- Yeo, 2011, The organization of the human cerebral cortex estimated by intrinsic functional connectivity, J Neurophysiol, 106, 1125, 10.1152/jn.00338.2011 · DOI · Paper page
- Hansson, 2017, Tau pathology distribution in Alzheimer’s disease corresponds differentially to cognition-relevant functional brain networks, Front Neurosci, 11, 167, 10.3389/fnins.2017.00167 · DOI · Paper page
- Jones, 2016, Cascading network failure across the Alzheimer’s disease spectrum, Brain, 139, 547, 10.1093/brain/awv338 · DOI · Paper page
- Xia, 2017, Association of in vivo [18F]AV-1451 tau PET imaging results with cortical atrophy and symptoms in typical and atypical Alzheimer disease, JAMA Neurol, 74, 427, 10.1001/jamaneurol.2016.5755 · DOI · Paper page
- Maass, 2018, Entorhinal tau pathology, episodic memory decline, and neurodegeneration in aging, J Neurosci, 38, 530, 10.1523/JNEUROSCI.2028-17.2017 · DOI · Paper page
- Hanseeuw, 2019, Association of amyloid and tau with cognition in preclinical Alzheimer disease, JAMA Neurol, 76, 915, 10.1001/jamaneurol.2019.1424 · DOI · Paper page
- Miller, 2013, Handedness and language learning disability differentially distribute in progressive aphasia variants, Brain, 136, 3461, 10.1093/brain/awt242 · DOI · Paper page
- Miller, 2018, Prevalence of mathematical and visuospatial learning disabilities in patients with posterior cortical atrophy, JAMA Neurol, 75, 728, 10.1001/jamaneurol.2018.0395 · DOI · Paper page
- Franzmeier, 2020, Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer’s disease, Sci Adv, 6, eabd1327, 10.1126/sciadv.abd1327 · DOI · Paper page
- Vogel, 2020, Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease, Nat Commun, 11, 2612, 10.1038/s41467-020-15701-2 · DOI · Paper page
- Mattsson, 2019, Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer’s disease, Alzheimers Dement, 15, 570, 10.1016/j.jalz.2018.12.001 · DOI · Paper page
- Park, 2020, Tau induces PSD95–neuronal NOS uncoupling and neurovascular dysfunction independent of neurodegeneration, Nat Neurosci, 23, 1079, 10.1038/s41593-020-0686-7 · DOI · Paper page
- Albrecht, 2020, Associations between vascular function and tau PET are associated with global cognition and amyloid, J Neurosci, 40, 8573, 10.1523/JNEUROSCI.1230-20.2020 · DOI
- Jones, 2017, Tau, amyloid, and cascading network failure across the Alzheimer’s disease spectrum, Cortex, 97, 143, 10.1016/j.cortex.2017.09.018 · DOI · Paper page
Cited by
Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
Boxer, A. L., & Sperling, R. (2023) · Cell · doi:10.1016/j.cell.2023.09.023 · Cited by 197
“6.(49) There are also other important drivers of tau pathology that are not fully understood.”
Boccalini, C., Ribaldi, F., Hristovska, I., Arnone, A., Peretti, D. E., Mu, L., Scheffler, M., Perani, D., Frisoni, G. B., & Garibotto, V. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13355 · Cited by 82
Appleton, J., Finn, Q., Zanotti-Fregonara, P., Yu, M., Faridar, A., Nakawah, M. O., Zarate, C., Carrillo, M. C., Dickerson, B. C., Rabinovici, G. D., et al. (2025) · Brain · doi:10.1093/brain/awae234 · Cited by 58
Self-citationLarge‐scale deep proteomic analysis in Alzheimer's disease brain regions across race and ethnicity
Seifar, F., Fox, E. J., Shantaraman, A., Liu, Y., Dammer, E. B., Modeste, E., Duong, D. M., Yin, L., Trautwig, A. N., Guo, Q., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.14360 · Cited by 52
Machine learning prediction of tau‐PET in Alzheimer's disease using plasma, MRI, and clinical data
Karlsson, L., Vogel, J., Arvidsson, I., Åström, K., Strandberg, O., Seidlitz, J., Bethlehem, R. A. I., Stomrud, E., Ossenkoppele, R., Ashton, N. J., et al. (2025) · Alzheimer's & Dementia · doi:10.1002/alz.14600 · Cited by 43
Self-citation
Metadata
- Authors
- Tanner, J. A., Iaccarino, L., Edwards, L., Asken, B. M., Gorno-Tempini, M. L., Kramer, J. H., Pham, J., Perry, D. C., Possin, K., Malpetti, M., Mellinger, T., Miller, B. L., Miller, Z., Mundada, N. S., Rosen, H. J., Soleimani-Meigooni, D. N., Strom, A., La Joie, R., & Rabinovici, G. D.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-06-28
- Volume
- 145
- Issue
- 12
- Pages
- 4489-4505
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W4283687741
- Cited by
- 91
- References
- 48
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- Funders
- National Institute on Aging (P30-AG062422)
- Alzheimer’s Disease Research Center (P01-AG019724, R35-AG072362, K99 AG065501, R01 AG045611)
- Alzheimer’s Association (AACSF-19-617663)
- Rainwater Charitable Foundation
- Race Against Dementia Alzheimer’s Research UK (ARUK-RADF2021A-010)
- Cambridge University Centre for Parkinson-Plus (RG95450)
- National Institute for Health Research Cambridge Biomedical Research Centre (BRC-1215-20014)
- Department of Health and Social Care
- NIH
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.